Human iPSC differentiation to retinal organoids in response to IGF1 and BMP4 activation is line- and method-dependent.
Induced pluripotent stem cell (iPSC)-derived retinal organoids provide a platform to study human retinogenesis, disease modelling and compound screening. Whilst retinal organoids may represent tissue structures with greater physiological relevance to the in vivo human retina, their generation is not without limitations. Various protocols have been developed to enable development of organoids with all major retinal cell types, however variability across iPSC lines is often reported. Modulating signalling pathways important for eye formation, such as those involving bone morphogenetic protein 4 (BMP4) and insulin-like growth factor (IGF1), is a common approach used for the generation of retinal tissue in vitro. We used three human iPSC lines to generate retinal organoids by activating either BMP4 or IGF1 signalling and assessed differentiation efficiency by monitoring morphological changes, gene and protein expression, and function. Our results showed that iPSC ability to give rise to retinal organoids in response to IGF1 and BMP4 activation was line- and method-dependent. This demonstrates that careful consideration is needed when choosing a differentiation approach, which would also depend on overall project aims. © AlphaMed Press 2019 SIGNIFICANCE STATEMENT: Using two different differentiation approaches involving either BMP4 or IGF1 signalling pathways, we derived retinal organoids from three human iPSC lines. We generated retinal organoids using both methods, however the two different approaches produced bias toward certain retinal cell types. The results of our work suggest that careful consideration is needed when choosing a differentiation protocol and that overall efficiency to generate retinal organoids would depend on the signalling pathways that are modulated.